谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 148 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
1769P Safety and Efficacy with Vimseltinib in Patients (pts) with Tenosynovial Giant Cell Tumor (TGCT) Who Received No Prior Anti–colony-Stimulating Factor 1 (CSF1) Therapy: Ongoing Phase II Study
C. Serrano,J-Y. Blay, P. Rutkowski, H. Gelderblom, S. Stacchiotti,A. Falcon Gonzalez, J. Desai, A. Le Cesne,V. Ferraresi,E. Palmerini,B.A. Wilky, A.J. Wagner,N.M. Bernthal, M. van de Sande, S. Narasimhan,B. Harrow, M.G. Sharma,R. Ruiz-Soto, M.L. Sherman,W.D. Tap
Annals of Oncology (2024)
引用0浏览0引用
0
0
53O Results from a Phase II Part I Trial of Mecbotamab Vedotin (BA3011), a CAB-AXL-ADC, in Patients with Advanced Refractory Sarcoma
S. Pollack,A.P. Conley,W.D. Tap,C-C. Yen, J. Charlson, L. Davis, A. Chalmers,M. Druta,E. Loggers, J.S. Grewal,G. Falchook, B. Schulte, T. Yau, A. Kim,H.H.F. Loong, S. George, B. Setty, L. Mascarenhas, G.M. Cote,B. Wilky
ESMO Open (2024)
引用0浏览0引用
0
0
Behaving Badly: Thinking Outside the Box for Treatment of Sarcoma in a Challenging Location
Breelyn A. Wilky,Ryan M. Lanning
International Journal of Radiation OncologyBiologyPhysicsno. 4 (2024): 1055-1056
引用0浏览0WOS引用
0
0
Peak Part 1 Summary: A Phase 3, Randomized, Open-Label Multicenter Clinical Study of Bezuclastinib (CGT9486) and Sunitinib Combination Versus Sunitinib in Patients with Gastrointestinal Stromal Tumors (GIST)
Andrew J. Wagner,Jonathan C. Trent, Steven Attia, Mark Agulnik,Breelyn A. Wilky,William D. Tap,Margaret von Mehren, Elizabeth J. Davis, Liangxing Zou, Nisha Shah, Kevin Moynihan, Julia Lawrence, Lei Sun,Neeta Somaiah
Journal of Clinical Oncologyno. 16_suppl (2024): 11533-11533
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 149

#Citation: 1968

H-Index: 23

G-Index: 42

Sociability: 7

Diversity: 2

Activity: 115

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn